BridgeMD
New treatment option for Localized Prostate Adenocarcinoma
Official title Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer
ClinicalTrials.gov ID: NCT07042256
What this study is testing
- What it's testing
- Hip replacements and prostate cancer are independently and both together increasing prevalent in the aging population. In the United States, the prevalence of hip prostheses among men was 1.1 million in 20101, with approximately 500,000 hip prostheses performed annually.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Diagnosis of localized prostate cancer suitable for definitive SBRT based on a multidisciplinary tumour board recommendation and / or clinical...
- Presence of bilateral hip prostheses labeled as MR safe or MR-conditional.
- ECOG performance status ≤ 2.
- Signed informed consent.
- Age ≥18 years -
You likely can't join if
- Large body size that would not fit into the MRI-simulator bore
- Hip prosthesis that are labeled as MR unsafe;
- Contraindications to MRI including but not limited to:
- Claustrophobia unmanageable by sedation
- Electronic devices such as pacemakers, defibrillators, deep brain stimulators, cochlear implants that are labeled as MR unsafe, electronic devices...
- Metallic foreign body in the eye or aneurysm clips in the brain;
See the full eligibility criteria
- Diagnosis of localized prostate cancer suitable for definitive SBRT based on a multidisciplinary tumour board recommendation and / or clinical practice guideline.
- Presence of bilateral hip prostheses labeled as MR safe or MR-conditional.
- ECOG performance status ≤ 2.
- Signed informed consent.
- Age ≥18 years -
- Large body size that would not fit into the MRI-simulator bore
- Hip prosthesis that are labeled as MR unsafe;
- Contraindications to MRI including but not limited to:
- Claustrophobia unmanageable by sedation
- Electronic devices such as pacemakers, defibrillators, deep brain stimulators, cochlear implants that are labeled as MR unsafe, electronic devices labeled as MR safe or MR conditional are not a contraindication;
- Metallic foreign body in the eye or aneurysm clips in the brain;
- Clinically significant concomitant diseases that would interfere with the study (e.g. hepatic dysfunction, cardiovascular disease).
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
- Enrolment of the investigator, his/her family members, employees and other dependent persons.
The study team makes the final eligibility decision.
Where it's taking place
- Zurich, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.